3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Classical hematology
1
Conditions
Colorectal Neoplasms
13
Stomach Neoplasms
7
Pancreatic Neoplasms
7
Colonic Neoplasms
4
Rectal Neoplasms
3
Pain, Postoperative
3
Neurotoxicity Syndromes
3
Lung Neoplasms
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Surgical Wound Infection
1
Stomatitis
1
Sigmoid Neoplasms
1
Recurrence
1
Ovarian Neoplasms
1
Neutropenia
1
Neoplasms
1
Melanoma
1
Lung Injury
1
Ileus
1
Hidrocystoma
1
Head and Neck Neoplasms
1
Gastrointestinal Stromal Tumors
1
Febrile Neutropenia
1
Fatigue
1
Esophageal Atresia
1
Endometrial Neoplasms
1
Interventions
Leucovorin
4
Fluorouracil
4
trifluridine tipiracil drug combination
2
Oxaliplatin
2
Irinotecan
2
Bevacizumab
2
pegfilgrastim
1
Sodium Chloride
1
N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
1
Moxibustion
1
Algorithms
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neutropenia
×
Sodium Chloride
×
Gastrointestinal
×
Clear all
NCT01619423
2018-07-06
PLIANT
Egetis Therapeutics
Phase 1/2
Completed
186 enrolled
12 charts